IRGM
Immunity-related GTPase family M protein
Also known as: IFI1, IRGM_HUMAN, IRGM1, LRG-47, LRG47
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A1A4Y4
- Gene
- IRGM
- Ensembl
- ENSG00000237693
- Chromosome
- 5
- Canonical length
- 181 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the p47 immunity-related GTPase family. The encoded protein may play a role in the innate immune response by regulating autophagy formation in response to intracellular pathogens. Polymorphisms that affect the normal expression of this gene are associated with a susceptibility to Crohn's disease and tuberculosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
181 residues, UniProt reviewed canonical sequence.
>A1A4Y4|IRGM
1 MEAMNVEKAS ADGNLPEVIS NIKETLKIVS RTPVNITMAG DSGNGMSTFI SALRNTGHEG
61 KASPPTELVK ATQRCASYFS SHFSNVVLWD LPGTGSATTT LENYLMEMQF NRYDFIMVAS
121 AQFSMNHVML AKTAEDMGKK FYIVWTKLDM DLSTGALPEV QLLQIRENVL ENLQKERVCE
181 YLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IRGM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 0.7 nTPM
Expression across tissuesHPA
Tissue
- testis: 0.7 nTPM
- bone marrow: 0.4 nTPM
- appendix: 0.3 nTPM
- retina: 0.3 nTPM
- skin: 0.3 nTPM
- spleen: 0.3 nTPM
Single-cell type
- thymocytes: 44 nCPM
- epicardial cells: 32 nCPM
- hematopoietic stem cells: 18 nCPM
- late primary spermatocytes: 17 nCPM
- mast cells: 14 nCPM
- t-cells: 14 nCPM
Immune cell
- basophil: 2.3 nTPM
- MAIT T-cell: 0.4 nTPM
- neutrophil: 0.4 nTPM
- gdT-cell: 0.2 nTPM
- memory CD4 T-cell: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
Brain region
- cerebellum: 4.3 nTPM
- pons: 2.9 nTPM
- cerebral cortex: 2.8 nTPM
- white matter: 2.7 nTPM
- hypothalamus: 2.6 nTPM
- midbrain: 2.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IRGM.
Disease | AllUniProt
Conditions IRGM is implicated in, by any mechanism.
- Inflammatory bowel disease 19 (IBD19) MIM:612278
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome assembly
- autophagosome maturation
- CAMKK-AMPK signaling cascade
- cellular response to interferon-beta
- cellular response to lipopolysaccharide
- cellular response to virus
- defense response to bacterium
- defense response to Gram-negative bacterium
- inflammatory response
- innate immune response
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of cGAS/STING signaling pathway
- negative regulation of defense response to virus
- negative regulation of inflammatory response
- negative regulation of NLRP3 inflammasome complex assembly
- negative regulation of type I interferon production
- negative regulation of type II interferon production
- nucleotide-binding oligomerization domain containing 2 signaling pathway
- positive regulation of autophagosome maturation
- positive regulation of autophagy
- positive regulation of lysosome organization
- positive regulation of macrophage activation
- positive regulation of mitochondrial fission
- positive regulation of mitophagy
- positive regulation of peptidyl-serine phosphorylation
- positive regulation of peptidyl-threonine phosphorylation
- positive regulation of protein phosphorylation
- positive regulation of protein serine/threonine kinase activity
- positive regulation of type II interferon-mediated signaling pathway
- positive regulation of xenophagy
- protein destabilization
- protein stabilization
- protein targeting to vacuole involved in autophagy
- protein-containing complex assembly
- regulation of protein complex stability
- regulation of protein-containing complex assembly
- protein lipidation involved in autophagosome assembly
Molecular functions
- BH3 domain binding
- CARD domain binding
- cardiolipin binding
- G protein activity
- GTP binding
- GTPase activity
- protein kinase binding
- protein serine/threonine kinase activator activity
- protein-macromolecule adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IRGM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IRGM as an antibody target. Whether an autoantibody or antibody against IRGM could matter depends on whether native IRGM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IRGM is annotated at the cell surface, where native IRGM is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IRGM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...